New: NCI-funded clinical trial search
Mednet Logo
SpecialtiesCardiology
Cardiology

Cardiology

Expert discussions on heart failure, arrhythmias, interventional procedures, and cardiovascular risk management.

Recent Discussions

How do you counsel patients with metabolic syndrome who decline statin therapy and have low coronary calcium scores regarding their long-term CVD risk?

3
3 Answers

Mednet Member
Mednet Member
Endocrinology · Duke Endocrinology Clinic

This is a great question with many ramifications, and I can only give an incomplete answer that includes personal opinion. First, what is the risk? The MESA Risk Score Calculator (check it out) gives a CAC percentile score as well as a 10-year risk. The 10-year risk may be low, but a high percentile...

What is a reasonable imaging modality for older patients with pAfib already on systemic anticoagulation outpatient but presenting with suspected cardioembolic stroke and TTE without evidence of LV thrombus?

3 Answers

Mednet Member
Mednet Member
Cardiology · The George Washington University Hospital

Gold standard is TEE.

For patients who have undergone ablation for atrial fibrillation with elevated bleeding risk, what is your risk/benefit approach when deciding to continue oral anticoagulation long-term?

3
1 Answers

Mednet Member
Mednet Member
Cardiology · Yale University School of Medicine

I would generally determine the continuation of anticoagulation based on the patient's ChADSVASC score rather than the perceived success of ablation as many will have a burden of subclinical PAF despite ablation. So, if they are at high risk for stroke/systemic embolism, based on ChADSVASC, I would ...

When do you think physicians should seriously consider prescribing PCSK9 inhibitors for the prevention of heart attack and stroke in people with ASCVD or diabetes, based on the results of the VESALIUS-CV trial?

4 Answers

Mednet Member
Mednet Member
Endocrinology · Newyork Presbyterian Columbia University Irving Medical Center

Although I checked 'high lipoprotein (a) as a reason to go with a PCSK9 first, I would almost never do it is practice. Statins first and then add a PCSK9 if LDL is above my goal for the patient. I might use a lower dose of the statin to get 35% lowering and then add the inhibitor if the patient was ...

How does LV non-compaction on TTE change your secondary stroke prevention management?

2 Answers

Mednet Member
Mednet Member
Neurology · Vanderbilt University Medical Center

Left ventricular non-compaction is a rare condition where the L atrial wall is thick and irregular and can contain areas of clot. I would favor anticoagulation in this situation, rather than antiplatelet therapy, but of course there are no clinical trials regarding this uncommon finding.

Are there instances when you recommend 48-hour ambulatory blood pressure monitoring over typical 24-hour studies for evaluation of patients with hypertensive kidney disease?

1 Answers

Mednet Member
Mednet Member
Nephrology · UAB Medicine

48-hour ambulatory BP monitoring can be helpful in gathering BP data for patients on hemodialysis with 3-day per week dialysis treatments. However, it is rarely done outside of research.

Do you routinely hold SGLT2 inhibitors prescribed for CHF or CKD in acutely ill patients upon admission to the hospital?

2
1 Answers

Mednet Member
Mednet Member
General Internal Medicine · University of Chicago

Thanks for this great question. The use of SGLT2 inhibitors in the hospital has been increasing dramatically, given their great effects on CKD and CHF for both diabetic and non-diabetic patients. There are simple direct contraindications for using SGLT2s, which would include patients with ketosis in...

Would you consider a secondary prevention ICD in a patient who had a cardiac arrest deemed attributable to a spontaneous coronary artery dissection (SCAD), with no intervention performed?

2
1 Answers

Mednet Member
Mednet Member
Cardiology · Mayo Clinic College of Medicine and Science

In patients who experience a cardiac arrest attributed to spontaneous coronary artery dissection (SCAD), the decision to pursue secondary prevention ICD implantation requires careful consideration of the reversibility of the underlying cause and the presence of any residual arrhythmogenic substrate....

How do you approach the decision to consult Cardiology and pursue an ischemic workup for an isolated troponin elevation attributable to a non-cardiac acute illness such as sepsis or acute respiratory failure?

4
2 Answers

Mednet Member
Mednet Member
Hospital Medicine · Northwestern Memorial Hospital

This decision is much more complex than can be adequately addressed in this response, based on the information given. The demographics and clinical risk factors of the patient are important in this decision, as well as the comfort of the clinician/primary care physician caring for the patient. Does ...

Do you prefer a loading dose of 300mg or 600mg plavix for patients presenting with NSTEMI or unstable angina about to undergo LHC?

2 Answers

Mednet Member
Mednet Member
Cardiology · Johns Hopkins University

Interesting question! As a rule of thumb, 600mg loads faster than 300mg. Therefore, it is more important when you anticipate your ballooning/stenting happening sooner rather than later (within minutes/hours). Per guidelines, Plavix is preferred over prasugrel/brilinta for stable angina (which was no...